99 150

Cited 0 times in

중증 부갑상선 기능 항진증에서 부갑상선내 Calcitriol 직접 주입술 및 충격요법 병용치료의 장기간 연구결과

DC Field Value Language
dc.contributor.author최규헌-
dc.date.accessioned2019-11-11T05:52:59Z-
dc.date.available2019-11-11T05:52:59Z-
dc.date.issued2000-
dc.identifier.issn1225-0015-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/172235-
dc.description.abstractSevere hyperparathyroidism(i-PTH>1,000pg/ml, dia-meter of nodules>1.0cm, and hypercalcemia) in dialysis patients may be resistant to conventional calcitriol- pulse therapy. To assess the usefulness of direct calcitriol injections in restoring the responsiveness to calcitriol, we performed a prospective study in 23 dialysis patients(mean age 42.3 years, M: F 0.9: 1, CGN 14, hypertension 4, lupus nephritis 2 & others 3, mean duration of dialysis 9.5 years, HD: CAPD 9: 14) who had severe hyperparathyroidism resistant to calcitriol pulse therapy for more than 2 months and had no ectopic gland in Sestamibi parathyroid scan. We three repeatedly injected calcitriol of dose(μg) equal to 3-D nodule volume(cm(3)) under U.S.(Acuson Computa Sono, California, USA, 7MHz probe) for 1 week and concurrently began calcitriol-pulse therapy(0.75-1.0μg/day, t.i.w.) after 3rd injection. All patients were followed up by serum i-FI H(Allegro Intact FPH kits, Nichols Ins.), calcium, phosphate, and U.S. after 7 days, 1 month, 6 months, and 1 year of 3rd calcitriol injection. These combination therapy could significantly decrease i-PTH level and gland volume in patients with resistant secondary hyperparathyroidism on conventional calcitriol therapy and the response were main-tained for one year after start of these therapy. The complete response group was the patients with lower baseline i-FFH levels compared to those with partial and non-response(1001.7±150.2 vs. 1521.8±328.3, 1569.2 ±344.3pg/ml, p<0.05, respectively). The patients with baseline i-PTH of less than l,200pg/ml or gland volume of less than 1.5cm were well responded to the three consecutive direct calcitriol injection and pulse combination therapy(i-PTH; PPV 77.8%, NPV 92.8%, gland volume', PPV 87.5%, NPU 93.3%). No severe adverse effect was observed during this study. In conclusion, direct calcitriol injections into the parathyroid nodules and pulse combination therapy could be useful in secondary resistant hyperparathyroidism patients with conventional calcitriol therapy especially in those with i-PTH of less than 1,200pg/ml or gland volume of less than 1.5cm. However, sugical management may be indicated in patients with higher i-PTEI levels or larger gland volume than these.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher대한신장학회-
dc.relation.isPartOfKorean Journal of Nephrology (대한신장학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.title중증 부갑상선 기능 항진증에서 부갑상선내 Calcitriol 직접 주입술 및 충격요법 병용치료의 장기간 연구결과-
dc.title.alternativeLong-term Results of Direct Calcitriol Injection into Parathyroid Nodules and Calcitriol-pulse Combination Therapy in Resistant Hyperparathyroidism-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthor신석균-
dc.contributor.googleauthor황재하-
dc.contributor.googleauthor송현용-
dc.contributor.googleauthor노현진-
dc.contributor.googleauthor강신욱-
dc.contributor.googleauthor최규헌-
dc.contributor.googleauthor임승길-
dc.contributor.googleauthor하성규-
dc.contributor.googleauthor한대석-
dc.contributor.googleauthor이호영-
dc.contributor.localIdA04043-
dc.relation.journalcodeJ02066-
dc.contributor.alternativeNameChoi, Kyu Hun-
dc.contributor.affiliatedAuthor최규헌-
dc.citation.volume19-
dc.citation.number1-
dc.citation.startPage91-
dc.citation.endPage100-
dc.identifier.bibliographicCitationKorean Journal of Nephrology (대한신장학회지), Vol.19(1) : 91-100, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.